has been an invited speaker at Biogen MA Inc., Danone, Eisai, WebMD Neurology (Medscape), Novo Nordisk, Springer Healthcare and European Brain Council
Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity
Peptides like ipamorelin or sermorelin increase natural growth hormone, which synergizes with GHK-Cu for skin quality, healing, and overall regeneration
Start your intake Why GLP-1 Medications Make Exercise Feel Harder GLP-1 receptor agonists reduce hunger by slowing stomach emptying and signaling fullness to the brain
Injection size: 10 L System suitability Sample: System suitability solution Suitability requirements Resolution: NLT 5.0 between the ascorbic acid and glutathione peaks
Combination therapies, novel receptor targets, and alternative delivery systems are in development, aiming to improve efficacy, tolerability, and convenience